#5 in our Live Chat series: Cannabis use is a reality in New Zealand. Despite almost 55 years of prohibition, it is New Zealand’s most widely used illicit drug. Evidence shows that up to 80% of New Zealanders will use cannabis at least once before they turn 21.
This September, New Zealanders will have the chance to make a historic decision – do we accept that the status quo has failed, and try something new? The Bill we’ll all be voting on at the referendum aims to put regulations in place to minimise the social and health harms of cannabis, and place much-needed controls around the existing illicit market.
Our amazing line up of panelists answered questions about legalisation in this Q&A co-hosted by the NZ Drug Foundation and the Helen Clark Foundation. The speakers covered the health impacts, the social justice and criminal justice impacts of legalisation. They gave an overview of what’s proposed in Aotearoa and put that in context of what’s happening internationally.
Join us for an intelligent discussion on why cannabis reform is the logical next step for our country.
Our panellists:
Co-chaired by Ross Bell, Executive Director of the Drug Foundation and Katherine Errington, Executive Director of the Helen Clark Foundation.
Wednesday 6 May: An overview of the Cannabis Control Bill [recording]
Thursday 28 May: What it means for medicinal cannabis users [recording]
Wednesday 10 June: Māori perspectives on the Cannabis Control Bill [recording]
Wednesday 24 June: Better outcomes for young people? [recording]
Wednesday 8 July: The case for a Yes vote [Recording]
A new report shows New Zealand’s failure to adequately diagnose and treat ADHD is likely leading to significant drug harm, including from alcohol and nicotine.
Our latest report pulls together international evidence and local experiences of how neurodivergence impacts drug use
‘Microdosing’ psychedelics involves taking small, repeated doses of a psychedelic drug. Researcher Robin Murphy talks us through the latest Auckland University microdosing study.